This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

Liverpool scientists awarded £1.5m to explore new pancreatic cancer treatments 12 February 2018

University of Liverpool scientists have been awarded £1.5million by Cancer Research UK to help boost understanding about pancreatic cancer – one of the deadliest cancers.

> Read More

Zilico Announces $19M from New Investments 7 February 2018

Zilico Ltd continues its global expansion plans for ZedScan™ by securing a strategic deal with the MaxHealth Medicine Group (China), stock code: 836163 (NEEQ). The deal will allow MaxHealth to sell and market ZedScan™, Zilico’s cervical cancer diagnostic system, to the Chinese market. The deal will see Zilico receive minimum royalties of $12million.

> Read More

Arcis Biotechnology Group aiming to raise £2m for prostate cancer testing research  7 February 2018

Warrington-based biotech firm Arcis Biotechnology Group is bidding to raise £2m to step up research and development for revolutionary prostate cancer testing. It will and accelerate commercial roll-out of ground-breaking test of rapid DNA/RNA extraction and preservation products that enable earlier and more accurate cancer detection.

> Read More